首页>Journal of thrombosis and thrombolysis>Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial
作者单位:Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA, United States[1]Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 350 Longwood Avenue[2]